HRT Financial’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

HRT Financial’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2	Closed	-$3K	–	970
2019 Q1	$3K	Hold	2	–	–	﹤0.01%	480
2018 Q4	$3K	Hold	2	–	–	﹤0.01%	567
2018 Q3	$4K	Buy	+2	New	+$5.78K	﹤0.01%	392

Other funds holding TMBR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFG

Nadler Financial Group Deerfield, Illinois $1.04B AUM 19.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HRT Financial's TMBR Position: Q2 2019 in Review

HRT Financial sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2019, closing a stake of 2 shares — an estimated $3K sold.

HRT Financial first reported a position in TMBR in Q3 2018 and held it in 3 quarters. The position peaked at $4K in Q3 2018. 14 funds tracked by Wall St. Rank hold TMBR as of Q2 2019.

HRT Financial reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
HRT Financial sold 2 Timber Pharmaceuticals, Inc. shares in Q2 2019, an estimated $3K.
HRT Financial first reported a position in Timber Pharmaceuticals, Inc. in Q3 2018 and held it in 3 quarters.
HRT Financial's Timber Pharmaceuticals, Inc. position peaked at $4K in Q3 2018.
14 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2019.

Based on HRT Financial's 13F filing for Q2 2019, filed 14 Aug 2019.